Ron Milo

Q: What Schools Are Affiliated With Ron Milo

Ron Milo is affiliated with the following schools: Weizmann Institute of Science, California Institute of Technology, Tel Aviv University, Hebrew University of Jerusalem, Ben-Gurion University of the Negev, Harvard University

Ron Milo's AcademicInfluence.com Rankings

Ron Milo

Biology

#6444

World Rank

#9159

Historical Rank

Biochemistry

#817

World Rank

#923

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Ron Milo Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ron Milo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Network motifs: simple building blocks of complex networks. (2002) (6648)
Revised Estimates for the Number of Human and Bacteria Cells in the Body (2016) (3111)
Network motifs in the transcriptional regulation network of Escherichia coli (2002) (3027)
The biomass distribution on Earth (2018) (1508)
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans (2016) (1283)
Superfamilies of Evolved and Designed Networks (2004) (1233)
BioNumbers—the database of key numbers in molecular and cell biology (2009) (835)
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel (2021) (777)
The moderately efficient enzyme: evolutionary and physicochemical trends shaping enzyme parameters. (2011) (749)
SARS-CoV-2 (COVID-19) by the numbers (2020) (679)
Oscillations and variability in the p53 system (2006) (641)
Waning Immunity after the BNT162b2 Vaccine in Israel (2021) (612)
Multiple sclerosis: geoepidemiology, genetics and the environment. (2010) (609)
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug (2008) (586)
Variability and memory of protein levels in human cells (2006) (575)
Efficient sampling algorithm for estimating subgraph concentrations and detecting network motifs (2004) (556)
Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction. (2004) (554)
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy (2011) (476)
Cell Biology by the Numbers (2015) (465)
eQuilibrator—the biochemical thermodynamics calculator (2011) (464)
A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions (2006) (453)
What is the total number of protein molecules per cell volume? A call to rethink some published values (2013) (448)
Glycolytic strategy as a tradeoff between energy yield and protein cost (2013) (404)
Design and analysis of synthetic carbon fixation pathways (2010) (379)
Land, irrigation water, greenhouse gas, and reactive nitrogen burdens of meat, eggs, and dairy production in the United States (2014) (368)
On the uniform generation of random graphs with prescribed degree sequences (2003) (361)
Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. (1993) (334)
Revised diagnostic criteria of multiple sclerosis. (2014) (276)
Conversion of Escherichia coli to Generate All Biomass Carbon from CO2 (2019) (248)
Cross-species analysis traces adaptation of Rubisco toward optimality in a low-dimensional landscape (2010) (247)
Visual account of protein investment in cellular functions (2014) (230)
Consistent Estimation of Gibbs Energy Using Component Contributions (2013) (228)
Pathway Thermodynamics Highlights Kinetic Obstacles in Central Metabolism (2014) (224)
Sugar Synthesis from CO2 in Escherichia coli (2016) (223)
A central role for Necl4 (SynCAM4) in Schwann cell–axon interaction and myelination (2007) (215)
Input–output robustness in simple bacterial signaling systems (2007) (201)
Rethinking glycolysis: on the biochemical logic of metabolic pathways. (2012) (201)
Global human-made mass exceeds all living biomass (2020) (194)
Central carbon metabolism as a minimal biochemical walk between precursors for biomass and energy. (2010) (193)
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions (1997) (192)
A survey of carbon fixation pathways through a quantitative lens. (2012) (192)
Topological generalizations of network motifs. (2003) (191)
The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. (2011) (189)
HSP90 affects the expression of genetic variation and developmental stability in quantitative traits (2008) (188)
SnapShot: Key Numbers in Biology (2010) (188)
Subgraphs in random networks. (2003) (187)
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel (2022) (175)
Promoters maintain their relative activity levels under different growth conditions (2013) (166)
Global characterization of in vivo enzyme catalytic rates and their correspondence to in vitro kcat measurements (2016) (159)
Spanning high-dimensional expression space using ribosome-binding site combinatorics (2013) (159)
SnapShot: Timescales in Cell Biology (2016) (146)
Dynamic proteomics in individual human cells uncovers widespread cell-cycle dependence of nuclear proteins (2006) (144)
Massively Parallel Interrogation of the Effects of Gene Expression Levels on Fitness (2016) (140)
Prediction of Microbial Growth Rate versus Biomass Yield by a Metabolic Network with Kinetic Parameters (2012) (136)
pH determines the energetic efficiency of the cyanobacterial CO2 concentrating mechanism (2016) (135)
Protection against Covid-19 by BNT162b2 Booster across Age Groups (2021) (133)
Coarse-graining and self-dissimilarity of complex networks. (2004) (121)
Design and analysis of metabolic pathways supporting formatotrophic growth for electricity-dependent cultivation of microbes. (2013) (118)
The Protein Cost of Metabolic Fluxes: Prediction from Enzymatic Rate Laws and Cost Minimization (2016) (118)
Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein. (1992) (113)
The distribution of cellular turnover in the human body (2021) (111)
The global mass and average rate of rubisco (2019) (110)
Thermodynamic constraints shape the structure of carbon fixation pathways. (2012) (109)
The opportunity cost of animal based diets exceeds all food losses (2018) (108)
An integrated open framework for thermodynamics of reactions that combines accuracy and coverage (2012) (108)
The total number and mass of SARS-CoV-2 virions (2021) (106)
Waning immunity of the BNT162b2 vaccine: A nationwide study from Israel (2021) (104)
"Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. (1991) (103)
Adaptive cyclic exit strategies from lockdown to suppress COVID-19 and allow economic activity (2020) (100)
A feeling for the numbers in biology (2009) (99)
Energy and protein feed-to-food conversion efficiencies in the US and potential food security gains from dietary changes (2016) (96)
Revisiting Trade-offs between Rubisco Kinetic Parameters (2019) (96)
Immunological Aspects of Approved MS Therapeutics (2019) (95)
Quantifying translational coupling in E. coli synthetic operons using RBS modulation and fluorescent reporters. (2013) (95)
Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS (2016) (87)
A note on the kinetics of enzyme action: A decomposition that highlights thermodynamic effects (2013) (86)
Interferon β-lb reduces Interferon γ-induced antigen-presenting capacity of human glial and B cells (1995) (83)
The Moderately Efficient Enzyme: Futile Encounters and Enzyme Floppiness. (2015) (81)
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections (2022) (79)
Noise in gene expression is coupled to growth rate (2015) (79)
Kashtan, N., Itzkovitz, S., Milo, R. & Alon, U. Efficient sampling algorithm for estimating subgraph concentrations and detecting network motifs. Bioinformatics 20, 1746-1758 (2004) (79)
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients (1996) (78)
Energetic cost of building a virus (2017) (78)
Steady-State Metabolite Concentrations Reflect a Balance between Maximizing Enzyme Efficiency and Minimizing Total Metabolite Load (2013) (72)
Therapeutic strategies targeting B-cells in multiple sclerosis. (2016) (71)
Generation of a fluorescently labeled endogenous protein library in living human cells (2007) (70)
Neurological features of West Nile Virus infection during the 2000 outbreak in a regional hospital in Israel (2002) (69)
Response to Comment on "Network Motifs: Simple Building Blocks of Complex Networks" and "Superfamilies of Evolved and Designed Networks" (2004) (68)
A Bird's-Eye View of Enzyme Evolution: Chemical, Physicochemical, and Physiological Considerations. (2018) (68)
Hydrophobicity and Charge Shape Cellular Metabolite Concentrations (2011) (67)
Protein Dynamics in Individual Human Cells: Experiment and Theory (2009) (64)
Achieving Diversity in the Face of Constraints: Lessons from Metabolism (2012) (64)
Design principles of autocatalytic cycles constrain enzyme kinetics and force low substrate saturation at flux branch points (2016) (61)
The Myelin-Associated Oligodendrocytic Basic Protein Region MOBP15–36 Encompasses the Immunodominant Major Encephalitogenic Epitope(s) for SJL/J Mice and Predicted Epitope(s) for Multiple Sclerosis-Associated HLA-DRB1*15011 (2004) (58)
Lessons on enzyme kinetics from quantitative proteomics. (2017) (51)
The total number and mass of SARS-CoV-2 virions (2020) (49)
Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome. (1980) (49)
Omicron infection enhances Delta antibody immunity in vaccinated persons (2022) (49)
Reconstructing a puzzle: existence of cyanophages containing both photosystem-I and photosystem-II gene suites inferred from oceanic metagenomic datasets. (2011) (49)
Additive effects of copolymer-1 and interferon β-1b on the immune response to myelin basic protein (1995) (49)
Uniform generation of random graphs with arbitrary degree sequences (2003) (48)
Highly active rubiscos discovered by systematic interrogation of natural sequence diversity (2020) (46)
Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells. (1995) (45)
Pyruvate Formate-Lyase Enables Efficient Growth of Escherichia coli on Acetate and Formate. (2016) (45)
Protection and waning of natural and hybrid COVID-19 immunity (2021) (43)
Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma. (1998) (42)
The relationship between evolutionary and physiological variation in hemoglobin (2007) (40)
The quantified cell (2014) (39)
Therapies for multiple sclerosis targeting B cells (2019) (39)
Assessment of GFP Tag Position on Protein Localization and Growth Fitness in Yeast. (2019) (37)
Networks Network Motifs: Simple Building Blocks of Complex (2008) (35)
The Biomass Composition of the Oceans: A Blueprint of Our Blue Planet (2019) (35)
Environmentally Optimal, Nutritionally Aware Beef Replacement Plant-Based Diets. (2016) (34)
Tau and 14-3-3 of genetic and sporadic Creutzfeldt–Jakob disease patients in Israel (2011) (34)
Photovoltaic-driven microbial protein production can use land and sunlight more efficiently than conventional crops (2021) (34)
Stroke in the Very Elderly: Characteristics and Outcome in Patients Aged ≥85 Years with a First-Ever Ischemic Stroke (2012) (32)
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis (2014) (32)
BNT162b2 vaccine booster dose protection: A nationwide study from Israel (2021) (31)
Functional reconstitution of a bacterial CO2 concentrating mechanism in Escherichia coli (2020) (30)
Engineering carbon fixation in E. coli: from heterologous RuBisCO expression to the Calvin-Benson-Bassham cycle. (2017) (30)
The utility of the Visual Analogue Scale for the assessment of depressive mood in cognitively impaired patients (2004) (30)
The genetic basis for the adaptation of E. coli to sugar synthesis from CO2 (2017) (30)
The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis (2020) (30)
A model for ‘sustainable’ US beef production (2017) (30)
High prevalence of malignant melanoma in Israeli patients with Parkinson’s disease (2011) (29)
Acute intermittent porphyria in pregnancy (1989) (28)
Delayed epidural hematoma a review (2005) (28)
A proof for loop-law constraints in stoichiometric metabolic networks (2012) (28)
A quantitative compendium of COVID-19 epidemiology (2020) (26)
What governs the reaction center excitation wavelength of photosystems I and II? (2009) (25)
Partitioning United States' feed consumption among livestock categories for improved environmental cost assessments (2014) (25)
Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis (2018) (25)
Efficiency in Evolutionary Trade-Offs (2012) (25)
Non-cholinergic, non-antidopaminergic treatment of chronic digestive symptoms suggestive of a motility disorder: a two-step pilot evaluation of cisapride (1984) (24)
Reply to ``Comment on `Subgraphs in random networks' '' (2004) (24)
Protection by 4th dose of BNT162b2 against Omicron in Israel (2022) (23)
Dynamic Proteomics of Human Protein Level and Localization across the Cell Cycle (2012) (20)
Effectiveness of multiple sclerosis treatment with current immunomodulatory drugs (2015) (20)
Effect of Propranolol and IFN-β on the Induction of MHC Class II Expression and Cytokine Production by IFN-γ in THP-1 Human Monocytic Cells (1998) (19)
Noise Genetics: Inferring Protein Function by Correlating Phenotype with Protein Levels and Localization in Individual Human Cells (2014) (19)
Translational research in neurology and neuroscience 2010: multiple sclerosis. (2010) (18)
Topological generalizations of network motifs. Phys Rev E 70:031909 (2004) (18)
Revisiting tradeoffs in Rubisco kinetic parameters (2018) (17)
BioNumbers: The Database of Useful Biological Numbers (2015) (17)
Protection Across Age Groups of BNT162b2 Vaccine Booster against Covid-19 (2021) (17)
A Minimalistic Resource Allocation Model to Explain Ubiquitous Increase in Protein Expression with Growth Rate (2015) (16)
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5 (2021) (15)
Towards a quantitative view of the global ubiquity of biofilms (2019) (15)
The Role of Synthetic Biology in Atmospheric Greenhouse Gas Reduction: Prospects and Challenges (2020) (13)
EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis (2020) (13)
Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses (2022) (12)
An In Vivo Metabolic Approach for Deciphering the Product Specificity of Glycerate Kinase Proves that Both E. coli’s Glycerate Kinases Generate 2-Phosphoglycerate (2015) (12)
Combination therapy in multiple sclerosis (2011) (12)
eQuilibrator 3.0: a database solution for thermodynamic constant estimation (2021) (11)
Understanding the Dynamics and Optimizing the Performance of Chemostat Selection Experiments (2018) (11)
Glatiramer Acetate or Interferon-β for Multiple Sclerosis? (1999) (11)
Parinaud syndrome: Any clinicoradiological correlation? (2017) (11)
Bilateral vestibular failure as a unique presenting sign in carcinomatous meningitis: case report (2001) (10)
Functional reconstitution of a bacterial CO2 concentrating mechanism in E. coli (2020) (10)
Effect of propranolol and IFN-beta on the induction of MHC class II expression and cytokine production by IFN-gamma IN THP-1 human monocytic cells. (1998) (10)
Mycosis fungoides – A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis (2018) (10)
Robust Control of PEP Formation Rate in the Carbon Fixation Pathway of C4 Plants by a Bi-functional Enzyme (2011) (10)
EAN guideline on palliative care of people with severe, progressive multiple sclerosis (2020) (10)
Author response: SARS-CoV-2 (COVID-19) by the numbers (2020) (10)
Frontal bone osteomyelitis complicating frontal sinusitis caused by Haemophilus influenzae type a. (1991) (9)
Local corticosteroid treatment for carpal tunnel syndrome: a 6-month clinical and electrophysiological follow-up study. (2009) (9)
Multiple sclerosis and chronic cerebrospinal venous insufficiency: a critical review (2011) (8)
Amitriptyline for intractable hiccup. (1988) (8)
The unmitigated profile of COVID-19 infectiousness (2021) (7)
Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals. (2021) (7)
Daclizumab and its use in multiple sclerosis treatment. (2017) (7)
Point mutations in topoisomerase I alter the mutation spectrum in E. coli and impact the emergence of drug resistance genotypes (2019) (7)
Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of “Humanized” Multiple Sclerosis-like Disease* (2015) (6)
Network motifs in biological networks: Roles and Generalizations (2003) (6)
Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine (2022) (6)
Tiapride as treatment for certain patients with idiopathic torsion dystonia. (1991) (6)
Mutation in West Nile Virus Structural Protein prM during Human Infection (2016) (6)
Familial Creutzfeldt–Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course (2020) (6)
Defining the Energetic Costs of Cellular Structures (2019) (6)
EcoTime—An intuitive quantitative sustainability indicator utilizing a time metric (2013) (6)
Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study (2022) (6)
Engineering Microbes to Produce Fuel, Commodities, and Food from CO2 (2020) (5)
The Moderately E ffi cient Enzyme : Futile Encounters and Enzyme (2015) (5)
Patient and caregiver involvement in formulation of guideline questions: Findings from the EAN Guideline on Palliative Care of People with Severe Multiple Sclerosis (2018) (5)
CSF fistula and tension pneumatocele 22 years after head injury. (1988) (4)
Recurring Harmonic Walks and Network motifs in Western Music (2006) (4)
[MULTIPLE SCLEROSIS THERAPY - 2019]. (2019) (3)
Initial protection against Omicron in children and adolescents by BNT162b2 (2022) (3)
The importance of time post-vaccination in determining the decrease in vaccine efficacy against SARS-CoV-2 variants of concern (2021) (3)
Purulent meningitis due to Pseudomonas aeruginosa successfully treated with colistin and piperacillin. (1985) (3)
Daclizumab for the treatment of adults with relapsing forms of multiple sclerosis (2017) (3)
Spotlight on daclizumab: its potential in the treatment of multiple sclerosis (2016) (2)
Robust Control of PEP Formation Rate in the Carbon Fixation Pathway of C 4 Plants by a Bifunctional Enzyme-Supplementary Information (2011) (2)
Modelling COVID19: Epidemiological Evidence and Model Misspecifications (2020) (2)
Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage (2021) (2)
Acute spinal cord ischemia treated with intravenous thrombolysis (2017) (2)
Caveats for Economists: Epidemiology-Based Modelling of COVID19 and Model Misspecifications (2020) (2)
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. Reply. (2022) (2)
Ofatumumab – A Potential Subcutaneous B-cell Therapy for Relapsing Multiple Sclerosis (2020) (2)
JC virus identified in a patient with persistent and severe West Nile virus disease (2019) (1)
Patient Values and Preferences: Findings from the EAN Guideline on Palliative Care of People with Severe Multiple Sclerosis (2018) (1)
Can We Offer More to Patients with Multiple Sclerosis (2015) (1)
CHAPTER 7. B Cell-based Therapies for Multiple Sclerosis (2019) (1)
Comment on: Subgraphs in random networks. Authors' reply (2004) (1)
A retrospective analysis of the development of seizure frequency in patients with seizures during a period of military conflict (2018) (1)
Reply to Tichenor: Proposed update to beef greenhouse gas footprint is numerically questionable and well within current uncertainty bounds (2015) (1)
Quantitative clarification of key questions about COVID-19 epidemiology (2020) (1)
Glatiramer Acetate Depot (extended-release) Phase IIa one-year study in patients with Relapsing-remitting Multiple Sclerosis: Safety, tolerability and efficacy – NEDA Analysis (P6.359) (2018) (1)
Dynamic proteomics in mammalian cells: capabilities and challenges. (2007) (1)
Protection against omicron severe disease 0-7 months after BNT162b2 booster (2022) (1)
Maximization of information transmission influences selection of native phosphorelay architectures (2021) (1)
Association between cervical disc disease and lesions of multiple sclerosis (2021) (1)
Systematic assessment of GFP tag position on protein localization and growth fitness in yeast (2018) (1)
The Anthropocene by the Numbers: A Quantitative Snapshot of Humanity's Influence on the Planet (2021) (1)
Interferon-β reduces antigen presentation in human cells (1994) (1)
The global biomass and number of terrestrial arthropods (2023) (0)
Network motifs in the t nscri tional regu ati network of Escherichia coli (2011) (0)
Abstract P282: First-ever Ischemic Stroke in the Very Elderly: Trends, Characteristics and Outcome in a National Registry (2012) (0)
JC virus identified in a patient with persistent and severe West Nile virus disease (2019) (0)
Subject Index Vol. 31, 1991 (1991) (0)
REALITIES AND PROSPECTS OF FUTURE COMPLEX PROCESSING OF PLANT RAW MATERIALS INTO BIOTHETANOL AND BY-PRODUCTS O. Obodovych, V. Sydorenko (2021) (0)
Author response: Functional reconstitution of a bacterial CO2 concentrating mechanism in Escherichia coli (2020) (0)
The development and use of the European academy of neurology guideline on palliative care in advanced progressive multiple sclerosis (2021) (0)
B cell targeted therapies in inflammatory autoimmune disease of the central nervous system (2023) (0)
Genetic Creutzfeldt‐Jakob disease in Turkish Jews—demographic and clinical features (2022) (0)
The genetic basis for the adaptation of E. coli to sugar synthesis from CO2 (2017) (0)
Long Term Treatments II 5 November 1997, Tuesday (1997) (0)
What influences selection of native phosphorelay architectures? (2020) (0)
Metabolism Achieving Diversity in the Face of Constraints : Lessons from (2012) (0)
Global human-made mass exceeds all living biomass (2020) (0)
Controversies in Neurology (CONy-10) Congress Lisbon Placebo controlled trials in NMO are unethical and not needed YES (2016) (0)
Omicron infection enhances Delta antibody immunity in vaccinated persons (2022) (0)
Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukemia after immunosuppressive treatment (2017) (0)
Natalizumab treatment for highly active children and juveniles multiple sclerosis patients : An Israeli collaborative study (S35.001) (2018) (0)
Engineering an evolutionary ladder for synthetic carbon fixation (2016) (0)
Principles of Systems Biology-No. 10. (2016) (0)
Is there horizontal transmission of Creutzfeldt-Jakob disease? (2023) (0)
The unmitigated profile of COVID-19 infectiousness 1 (0)
Increased concentration of proteins with growth rate as a result of passive resource redistribution (2015) (0)
Reply to Metson et al.: The importance of phosphorus perturbations (2014) (0)
Mechanisms of interferon-beta effect in multiple sclerosis (1996) (0)
The global biomass of wild mammals (2023) (0)
University of Groningen Prediction of Microbial Growth Rate versus Biomass Yield by a Metabolic Network with Kinetic Parameters Adadi, (2012) (0)
A model for ‘sustainable’ US beef production (2017) (0)
Efficacy of "alarm stroke code" implementation - experience of the Barzilai University Medical Center (BUMC) (2017) (0)
Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster (2023) (0)
In Memoriam: Hillel S. Panitch, MD (1940-2010) (2011) (0)
Infective endocarditis mimicking parkinsonism and rapidly progressive dementia (2016) (0)
4-31-06 Serum cytokines and adhesion molecules in patients treated with interferon-beta 1b (betaferon), and copolymer-1 (copaxone): A one year follow-up (1997) (0)
Protection following BNT162b2 booster substantially exceeds that of a fresh 2-dose vaccine: a quasi-experimental study (2021) (0)
Contents Vol. 31, 1999 (1999) (0)
The distribution of cellular turnover in the human body (2021) (0)
NPGRJ_NMETH_892 525..531 (2006) (0)
EAN Guidelines EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis (0)
Specific inhibition by the synthetic copolymer COP-1 of human T cell lines specific to myelin basic protein (1991) (0)
A case of tetanus infection following hand injury (2018) (0)
Interferonβ-1b reduces antigen presentation to human T-cells (1995) (0)
Immunodominant epitopes of the autoimmune response to myelin oligodendrocyte glycoprotein in multiple sclerosis (1997) (0)
Consumer involvement in formulation of the questions to be answered: findings from the EAN Guideline on Palliative Care of People with severe Multiple Sclerosis (2018) (0)
Sclerosis-Associated HLA-DRB1*1501 and Predicted Epitope(s) for Multiple Encephalitogenic Epitope(s) for SJL/J Mice Encompasses the Immunodominant Major 36 - Basic Protein Region MOBP15 The Myelin-Associated Oligodendrocytic (2004) (0)
The consequences of switching from Gilenya® to generics for fingolimod. (2023) (0)
mixed-isotype heterodimer in the pathogenesis of ‘ humanized ’ multiple sclerosis-like disease Running Title : Potential effect on MS from DQA 1 * 01 : 02 ; DRB 1 * 15 : 01 (2015) (0)
Acknowledgement of Reviewers for 2018 (2019) (0)
Placebo controlled treatment in neuromyelitis optica ( NMO ) are unethical and not needed DEBATE (2016) (0)
Anthroponumbers.org: A quantitative database of human impacts on Planet Earth (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ron Milo?

Ron Milo is affiliated with the following schools:

Ron Milo's Academic­Influence.com Rankings

Why Is Ron Milo Influential?

Ron Milo's Published Works

Published Works

What Schools Are Affiliated With Ron Milo?

Ron Milo's AcademicInfluence.com Rankings